Article
Use of multiple biomarkers for a molecular diagnosis of prostate cancer
17 Dec 2004
Abstract excerpt
The identification of biomarkers capable of providing a reliable molecular diagnostic test for prostate cancer (PCa) is highly desirable clinically. We describe here 4 biomarkers, UDP-N-Acetyl-alpha-D-galactosamine transferase (GalNAc-T3; not previously associated with PCa), PSMA, Hepsin and DD3/PCA3, which, in combination, distinguish prostate cancer from benign prostate hyperplasia (BPH). GalNAc-T3 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
